Positions

Overview

  • Thomas Wang, M.D., Ph.D., joined the UAB Department of Surgery Division of Surgical Oncology in 2007. Dr. Wang is a prolific author and researcher with over six book chapters and numerous publications. He presents his clinical and research findings on a national level. He is a committed medical educator serving as the Co-Director of the Surgical Oncology Conference—training both residents and medical students. In 2014, he received the Argus Award which recognized his excellence in post-doctoral teaching for hematology-oncology.

    Dr. Wang’s clinical interests include thyroid and parathyroid diseases, adrenal neoplasms, pancreatic and hepatobiliary tumors, gastrointestinal malignancies, melanoma and soft tissue sarcomas.
  • Selected Publications

    Academic Article

    Year Title Altmetric
    2018 How academically productive are endocrine surgeons in the United States?Journal of Surgical Research.  229:122-126. 2018
    2018 Reducing cost and improving operating room efficiency: examination of surgical instrument processingJournal of Surgical Research.  229:15-19. 2018
    2016 Improved Postoperative Survival for Intraductal-Growth Subtype of Intrahepatic Cholangiocarcinoma.American Surgeon.  82:1133-1139. 2016
    2016 Improved postoperative survival for intraductal- growth subtype of intrahepatic cholangiocarcinomaAmerican Surgeon.  82:1133-1139. 2016
    2016 Impact of adjuvant chemoradiation on survival in patients with resectable cholangiocarcinomaHPB.  18:843-850. 2016
    2016 Timed Stair Climbing is the Single Strongest Predictor of Perioperative Complications in Patients Undergoing Abdominal SurgeryJournal of The American College of Surgeons.  222:559-566. 2016
    2016 Compromised Outcome of Papillary Thyroid Cancer at Low-Volume Treatment Centers: Practice Makes Perfect?Annals of Surgical Oncology.  23:355-357. 2016
    2015 Anaplastic thyroid carcinoma, version 2.2015Journal of the National Comprehensive Cancer Network.  13:1140-1150. 2015
    2014 Thyroid carcinoma, version 2.2014.Journal of the National Comprehensive Cancer Network.  12:1671-1680. 2014
    2014 Thyroid carcinoma, version 2.2014: Featured updates to the NCCN guidelinesJournal of the National Comprehensive Cancer Network.  12:1671-1680. 2014
    2010 Thyroid carcinomaJournal of the National Comprehensive Cancer Network.  8:1228-1274. 2010
    2010 Medullary carcinoma.Journal of the National Comprehensive Cancer Network.  8:512-530. 2010
    2010 Medullary carcinoma: Clinical practice guidelines in oncology™Journal of the National Comprehensive Cancer Network.  8:512-530. 2010
    2009 The role of angiocidin in sarcomasCancer.  115:5251-5262. 2009
    2009 Fibroblast-conditioned media promote human sarcoma cell invasionSurgery.  145:42-47. 2009
    2005 Macrophage inflammatory protein-3α promotes pancreatic cancer cell invasionJournal of Surgical Research.  123:96-101. 2005
    2004 Co-localization of macrophage inflammatory protein-3α (Mip-3α) and its receptor, CCR6, promotes pancreatic cancer cell invasionCancer Journal.  10:374-380. 2004
    2004 Antiangiogenic therapyCurrent Pharmaceutical Design.  10:27-37. 2004
    2002 Fibroblasts promote breast cancer cell invasion by upregulating tumor matrix metalloproteinase-9 productionSurgery.  132:220-225. 2002
    2001 Neoadjuvant therapy for gastric cancerAsian Journal of Surgery.  24:235-241. 2001
    1997 Thrombospondin-1 modulates angiogenesis in vitro by up-regulation of matrix metalloproteinase-9 in endothelial cellsExperimental Cell Research.  235:403-412. 1997
    1997 Adhesive proteins and the hematogenous spread of cancerActa Haematologica.  97:29-39. 1997
    1997 Thrombospondin-1 and transforming growth factor-beta1 promote breast tumor cell invasion through up-regulation of the plasminogen/plasmin systemSurgery.  122:493-500. 1997
    1996 Inhibition of breast cancer progression by an antibody to a thrombospondin-1 receptorSurgery.  120:449-454. 1996
    1996 Thrombospondin-1 (TSP-1) promotes the invasive properties of human breast cancerJournal of Surgical Research.  63:39-43. 1996
    1995 The effect of thrombospondin on oral squamous carcinoma cell invasion of collagenAmerican Journal of Surgery.  170:502-505. 1995

    Research Overview

  • pancreatic, hepatobiliary and gastrointestinal malignancies, surgical endocrine diseases, optimization of surgical resident curriculum to focus on the conceptual understanding of disease processes and patient management
  • Education And Training

  • Doctor of Medicine, Temple University 1991
  • Hahnemann University Hospital, Internship 1992
  • Hahnemann University Hospital, Residency 1999
  • MD Anderson Cancer Center, Postdoctoral Fellowship 2001
  • Full Name

  • Thomas Wang